Francis Medical, Inc., a privately held medical device company, announced today the successful completion of the first commercial (non-clinical study) procedure on the East Coast using the Vanquish(R) ...

– First multicenter, randomized controlled trial directly comparing a new technology to robotic RP for men with localized prostate cancer to successfully recruit to target enrollment – – TULSA ...

Prostate cancer affects one in eight men in the U.S. over their lifetime, which is the same rate as women and breast cancer.

AN ANNUAL free prostate cancer screening for men aged 40 and above has been proposed at the Cebu City Council to strengthen preventive healthcare and promote ea ...

MINNEAPOLIS, March 25, 2026 /PRNewswire/ -- Francis Medical, Inc., a privately held medical device company, announced today the successful completion of the first commercial (non-clinical study) ...

Cebu City male residents in their 40s and above could soon take advantage of free annual prostate cancer screening and consultations at the Cebu City Medical Center, following a resolution passed by ...

But what makes Tewari compelling is not just the scale of his achievement. It is the moral clarity with which he speaks about ...

Where previous research showed that PSMA therapy for prostate cancer can prolong the lives of patients who have exhausted all ...

A quiet signal inside a tumor may soon guide how surgeons treat early lung cancer. Researchers now report that hidden genetic ...

A randomized study in 58 men with limited metastatic prostate cancer found that PSMA therapy postponed the need for hormone ...